1. Home
  2. XMAX vs MYGN Comparison

XMAX vs MYGN Comparison

Compare XMAX & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XMAX Inc. Common Stock

XMAX

XMAX Inc. Common Stock

N/A

Current Price

$8.78

Market Cap

529.8M

ML Signal

N/A

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$3.02

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XMAX
MYGN
Founded
N/A
1991
Country
United States
United States
Employees
22
N/A
Industry
Home Furnishings
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
529.8M
444.2M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
XMAX
MYGN
Price
$8.78
$3.02
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$7.64
AVG Volume (30 Days)
790.1K
1.7M
Earning Date
N/A
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$771,400,000.00
Revenue This Year
N/A
$6.86
Revenue Next Year
N/A
$5.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.33
52 Week Low
$8.10
$2.81
52 Week High
$9.31
$8.59

Technical Indicators

Market Signals
Indicator
XMAX
MYGN
Relative Strength Index (RSI) 59.50 24.59
Support Level $8.33 N/A
Resistance Level $9.31 $5.17
Average True Range (ATR) 0.21 0.33
MACD 0.01 -0.35
Stochastic Oscillator 66.99 7.45

Price Performance

Historical Comparison
XMAX
MYGN

About XMAX XMAX Inc. Common Stock

XMax Inc is a designer and lifestyle furniture company. The company is a designer and distributor of contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. The company plans expansion into artificial intelligence (AI) while continuing to operate and develop its existing furniture business.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: